{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:25Z","timestamp":1790115025516,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The continued spread of SARS-CoV-2 increases the probability of influenza\/SARS-CoV-2 coinfection, which may result in severe disease. In this study, we examine the disease outcome of influenza A virus (IAV) and SARS-CoV-2 coinfection in K18-hACE2 mice. Our data indicate enhance susceptibility of IAV-infected mice to developing severe disease upon coinfection with SARS-CoV-2 two days later. In contrast to nonfatal influenza and lower mortality rates due to SARS-CoV-2 alone, this coinfection results in severe morbidity and nearly complete mortality. Coinfection is associated with elevated influenza viral loads in respiratory organs. Remarkably, prior immunity to influenza, but not to SARS-CoV-2, prevents severe disease and mortality. This protection is antibody-dependent. These data experimentally support the necessity of seasonal influenza vaccination for reducing the risk of severe influenza\/COVID-19 comorbidity during the COVID-19 pandemic.<\/jats:p>","DOI":"10.1038\/s41467-021-26113-1","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T09:52:53Z","timestamp":1633427573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-8628","authenticated-orcid":false,"given":"Hagit","family":"Achdout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-8551","authenticated-orcid":false,"given":"Einat. B.","family":"Vitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yfat","family":"Yahalom-Ronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Erez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-3372","authenticated-orcid":false,"given":"Roy","family":"Avraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Bar-Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efi","family":"Makdasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Aftalion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Chitlaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Vagima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-9660","authenticated-orcid":false,"given":"Nir","family":"Paran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-4477","authenticated-orcid":false,"given":"Tomer","family":"Israely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"26113_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"26113_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76404-8","volume":"10","author":"ABMMK Islam","year":"2020","unstructured":"Islam, A. B. M. M. K. & Khan, M. A.-A.-K. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. Sci. Rep. 10, 19395 (2020).","journal-title":"Sci. Rep."},{"key":"26113_CR3","doi-asserted-by":"publisher","first-page":"e0240781","DOI":"10.1371\/journal.pone.0240781","volume":"15","author":"J Regina","year":"2020","unstructured":"Regina, J. et al. Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study. PLoS ONE 15, e0240781 (2020).","journal-title":"PLoS ONE"},{"key":"26113_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83642-x","volume":"11","author":"KW Kim","year":"2021","unstructured":"Kim, K. W. et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Sci. Rep. 11, 3934 (2021).","journal-title":"Sci. Rep."},{"key":"26113_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury, L., Lim, B., Baskaran, V. & Lim, W. S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J. Infect. 81, 266\u2013275 (2020).","journal-title":"J. Infect."},{"key":"26113_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ijid.2021.02.087","volume":"105","author":"V Singh","year":"2021","unstructured":"Singh, V., Upadhyay, P., Reddy, J. & Granger, J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int. J. Infect. Dis. 105, 617\u2013620 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"26113_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"C-C Lai","year":"2020","unstructured":"Lai, C.-C., Wang, C.-Y. & Hsueh, P.-R. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J. Microbiol. Immunol. Infect. 53, 505\u2013512 (2020).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"26113_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/v13010130","volume":"13","author":"A Peci","year":"2021","unstructured":"Peci, A. et al. Prevalence of co-infections with respiratory viruses in individuals investigated for SARS-CoV-2 in Ontario, Canada. Viruses 13, 130 (2021).","journal-title":"Viruses"},{"key":"26113_CR9","doi-asserted-by":"publisher","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","volume":"16","author":"JS Musuuza","year":"2021","unstructured":"Musuuza, J. S. et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE 16, e0251170 (2021).","journal-title":"PLoS ONE"},{"key":"26113_CR10","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu). Available from: https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html (2020). Accessed 11 Jun 2021."},{"key":"26113_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrmicro3231","volume":"12","author":"JA McCullers","year":"2014","unstructured":"McCullers, J. A. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat. Rev. Microbiol. 12, 252\u2013262 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"26113_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/infdis\/jit190","volume":"208","author":"AR Falsey","year":"2013","unstructured":"Falsey, A. R. et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J. Infect. Dis. 208, 432\u2013441 (2013).","journal-title":"J. Infect. Dis."},{"key":"26113_CR13","doi-asserted-by":"crossref","unstructured":"Chan, K. et al. Investigating viral interference between influenza A virus and human respiratory syncytial virus in a ferret model of infection. J. Infect. Dis. 218, 406\u2013417 (2018).","DOI":"10.1093\/infdis\/jiy184"},{"key":"26113_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/infdis\/jix509","volume":"217","author":"K Laurie","year":"2018","unstructured":"Laurie, K. et al. Evidence for viral interference and cross-reactive protective immunity between influenza B virus lineages. J. Infect. Dis. 217, 548\u2013559 (2018).","journal-title":"J. Infect. Dis."},{"key":"26113_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19891-7","volume":"11","author":"FS Oladunni","year":"2020","unstructured":"Oladunni, F. S. et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 11, 6122 (2020).","journal-title":"Nat. Commun."},{"key":"26113_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2010.12.047","volume":"412","author":"P Blazejewska","year":"2011","unstructured":"Blazejewska, P. et al. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology 412, 36\u201345 (2011).","journal-title":"Virology"},{"key":"26113_CR17","doi-asserted-by":"publisher","first-page":"27142","DOI":"10.1073\/pnas.1911083116","volume":"116","author":"S Nickbakhsh","year":"2019","unstructured":"Nickbakhsh, S. et al. Virus\u2013virus interactions impact the population dynamics of influenza and the common cold. Proc. Natl Acad. Sci. USA 116, 27142\u201327150 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26113_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vaccine.2019.10.005","volume":"38","author":"GG Wolff","year":"2020","unstructured":"Wolff, G. G. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017\u20132018 influenza season. Vaccine 38, 350\u2013354 (2020).","journal-title":"Vaccine"},{"key":"26113_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43632-6","volume":"9","author":"RE Rigby","year":"2019","unstructured":"Rigby, R. E., Wise, H. M., Smith, N., Digard, P. & Rehwinkel, J. PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection. Sci. Rep. 9, 7216 (2019).","journal-title":"Sci. Rep."},{"key":"26113_CR20","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer, U. et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J. Biol. Chem. 295, 13958\u201313964 (2020).","journal-title":"J. Biol. Chem."},{"key":"26113_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virol.2015.05.021","volume":"484","author":"MS McAfee","year":"2015","unstructured":"McAfee, M. S., Huynh, T. P., Johnson, J. L., Jacobs, B. L. & Blattman, J. N. Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology 484, 153\u2013162 (2015).","journal-title":"Virology"},{"key":"26113_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","volume":"31","author":"L Bai","year":"2021","unstructured":"Bai, L. et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 31, 395\u2013403 (2021).","journal-title":"Cell Res."},{"key":"26113_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"26113_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","volume":"589","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603\u2013607 (2021).","journal-title":"Nature"},{"key":"26113_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","volume":"182","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies. Cell 182, 744\u2013753.e744 (2020).","journal-title":"Cell"},{"key":"26113_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4049\/jimmunol.171.2.915","volume":"171","author":"H Achdout","year":"2003","unstructured":"Achdout, H. et al. Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 171, 915\u2013923 (2003).","journal-title":"J. Immunol."},{"key":"26113_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20228-7","volume":"11","author":"Y Yahalom-Ronen","year":"2020","unstructured":"Yahalom-Ronen, Y. et al. A single dose of recombinant VSV-\u2206G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 6402 (2020).","journal-title":"Nat. Commun."},{"key":"26113_CR28","doi-asserted-by":"crossref","unstructured":"Israely, T. et al. Differential response following infection of mouse CNS with virulent and attenuated vaccinia virus strains. Vaccines 7, 19 (2019).","DOI":"10.3390\/vaccines7010019"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26113-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:47:12Z","timestamp":1669978032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26113"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26113-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-136702\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5819"}}